उत्पाद विवरण
Borviz 3.5 mg Injection is a targeted anticancer therapy specifically designed to combat multiple myeloma and mantle cell lymphoma, both aggressive forms of blood cancer. By inhibiting the activity of certain proteins within cancer cells, Borviz effectively disrupts their growth and promotes cell death, helping to manage these challenging conditions. This medication is administered via injection, ensuring direct delivery for optimal effectiveness. Patients should be aware of potential side effects, including fatigue and risk of infections, as it may affect immune function. Regular monitoring and consultation with healthcare professionals are crucial during treatment to ensure safety and efficacy. If you or a loved one are facing a diagnosis of multiple myeloma or mantle cell lymphoma, discussing Borviz 3.5 mg with your oncologist may provide valuable insights into your treatment options. Always follow your doctor's guidance regarding dosage and administration to achieve the best possible outcomes.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese